Your browser doesn't support javascript.
loading
Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
Gautam, Rupesh K; Mittal, Pooja; Goyal, Rajat; Dua, Kamal; Mishra, Dinesh Kumar; Sharma, Sanjay; Singla, Rajeev K.
Afiliación
  • Gautam RK; Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
  • Mittal P; Indore Institute of Pharmacy, IIST Campus, Rau, Indore-453331, Madhya Pradesh, India.
  • Goyal R; Chitkara College of Pharmacy, Chitkara University, Rajpura-Punjab, India-140401.
  • Dua K; MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be) University, Mullana-Ambala, Haryana, India.
  • Mishra DK; Discipline of Pharmacy Graduate School of Health Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) University of Technology Sydney, Sydney, Australia.
  • Sharma S; Indore Institute of Pharmacy, IIST Campus, Rau, Indore-453331, Madhya Pradesh, India.
  • Singla RK; Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, Vile Parle (W), Mumbai-400 056, India.
Curr Med Chem ; 2023 Oct 11.
Article en En | MEDLINE | ID: mdl-37828674
ABSTRACT
Nanomedicine's application of nanotechnology in medicine holds tremendous potential for diagnosing and treating life-threatening diseases such as cancer. Unlike conventional therapies, nanomedicine offers a promising strategy to enhance clinical outcomes while minimizing severe side effects. The principle of drug targeting enables specific delivery of therapeutic agents to their intended sites, making it a more precise and effective therapy. Combination strategies, such as the co-delivery of chemotherapeutic drugs with nucleic acids or receptor-specific molecules, are being employed to enhance therapeutic outcomes. Nanocarriers and drug delivery systems designed using these approaches offer resourceful co-delivery of therapeutic agents for anticancer therapy. Targeted drug delivery via nanotechnology-based techniques has become an urgent need and has shown significant improvements in therapeutic implications, pharmacokinetics, specificity, reduced toxicity, and biocompatibility. This review discusses the extrapolation of nanomaterials for developing innovative and novel drug delivery systems for effective anticancer therapy. Additionally, we explore the role of nanotechnology-based concepts in drug delivery research.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article